Women are more likely to need walking sticks, wheelchairs and other mobility aids compared to men, but they are less likely to use them, according to a study. And single people are more likely to use mobility tools compared to those who are married, according to researchers from University College London (UCL) and the London School of Hygiene and Tropical Medicine (LSHTM). Researchers looked at information from a group of more than 12,000 adults in England aged 50 to 89 who were tracked over a 13-year period. At the start of the study, 8,225 adults had no mobility difficulty and did not use mobility assistive products (MAPs). Some 2,480 were deemed to have “unmet need” and 1,375 were using mobility aids. During the follow-up period, there were 2,313 “transitions” where people went from having no mobility issues to needing some help with getting around. And 1,274 people started to use mobility aids. Compared with men, women were 49% more likely to transition from not needing mobility aids to needing to use them, according to the study which has been published in The Lancet Public Health. But were 21% less likely to go on to use mobility aids when they needed them. The authors said their study showed “barriers to access” for women. For both men and women, with every year that passed during the study period the need for mobility aids increased. People who were older, less educated, less wealthy or reported being disabled were more likely to “transition from no need to unmet need, and from unmet need to use”, the authors said, with this indicating a “higher prevalence of mobility limitations and MAP need overall among these groups”. They added: “Finally, marital or partnership status was not associated with transitioning to unmet need; however, single people were more likely to transition from unmet need to use compared with married or partnered people.” Jamie Danemayer, first author of the study from UCL Computer Science and UCL’s Global Disability Innovation Hub, said: “Our analysis suggests that there is a clear gender gap in access to mobility aids. “Though our data didn’t ascertain the reason why participants weren’t using mobility aids, other research tells us that women are often more likely than men to face obstacles such as cost barriers as a result of well-documented income disparities between genders. “Many mobility aids are designed for men rather than women, which we think may be a factor. “Using mobility aids can also make a disability visible, which can impact the safety and stigma experienced by women, in particular. “There’s a critical need for further research to identify and break down the barriers preventing women from accessing mobility aids that would improve their quality of life.” Professor Cathy Holloway, also from UCL, added: “Not having access to mobility aids when a person needs one can have a big impact on their independence, well-being and quality of life. “Our analysis suggests that women, in particular, regardless of other factors such as education and employment status, are not getting the support that they need.” Professor Shereen Hussein, senior author of the study and lead of the social care group at the London School of Hygiene & Tropical Medicine, said: “The research provides compelling evidence of gender disparities in accessing assistive technology, suggesting that cost, design bias, and social stigma are likely to disproportionally affect women. “This underscores the need for inclusive, gender-sensitive approaches in the design, production and inclusivity of assistive technologies.”Major Drilling Appoints Chief Operating Officer to Support Continued Growth in Operations and Technologies
AI stock ( ) and Bitcoin ETF provider ( ) lead five top companies to watch near buy points this week. China stock ( ) also makes the cut, along with ( ) and ( ). Top Stocks Show Strength Near Buy Points Nvidia stock found support to regain a buy point last week while BlackRock stock offered an early entry. Shares of artificial intelligence chipmaker Nvidia are consolidating near record highs ahead of a possible new run. The other three top stocks to watch trade just below buy points and their 52-week highs. Notably, Nvidia stock earns a spot on two top IBD lists: and the . Also on Leaderboard: GraniteShares 2x Short NVDA Daily ETF ( ), offering investors a way to hedge a long Nvidia position as the chipmaker trades above all of its moving averages. And on IBD 50: Emcor stock, which is winding up for its next move in a bullish pattern. The for all five top stocks to watch this week are rising and not far from highs. A rising RS line, the blue line in the charts shown, signals outperformance vs. the S&P 500 index. It would be a positive sign to see this price strength indicator move to an all-time high as the stocks try to break out or extend breakouts. The S&P 500 and Nasdaq t hit record highs on Friday. Investors viewed a Goldilocks jobs report as keeping the Fed on its rate-cutting path. But analysts warned of signs of investor fatigue beneath the surface. Nvidia Stock An AI Winner Shares of the AI chipmaker popped back above a 140.76 last week, rebounding from the 50-day/10-week moving averages. Investors could use the $150 price area as an alternate or add-on entry from clearing the bulk of the recent trading range. The Nvidia stock chart shows it has been consolidating since late June. The 10-week bounce could signal NVDA is gathering strength for another run. Shares did fall on Friday, but held the 21-day moving average. The RS line for the AI stock has moved sideways since June with the shares, according to the . It rallied strongly in the first half of the year and remains near all-time highs. Nvidia earns an of 97, EPS Rating of 99, and RS Rating of 95, all out of a best-possible 99. The 95 RS Rating means that Nvidia stock has outperformed 95% of all stocks in IBD's database over the past year. Nvidia's earnings more than doubled in the third quarter ended Oct. 27. Though impressive, growth actually slowed vs. the previous five quarters. The AI chip giant grew earnings at a redoubtable 236% pace over the past three quarters, according to the . That is far above the three-year average rate of 94%. For the full year, analysts expect Nvidia earnings per share to more than double, vaulting 127%. They expect earnings growth to slow to a still-robust 49% next year. Recent news indicates demand for Nvidia's AI chips remains high. UBS Global Wealth Management said: "Big Tech's combined capex (capital expenditure) spending of $218 billion this year and another $254 billion in 2025 bodes well for the AI investment thesis." Year to date, has nearly tripled, up 188%. That includes a nearly 20% gain in the current quarter amid quarterly earnings and the presidential election. BlackRock Stock Rides Bitcoin ETF Success Shares of the investment giant snapped a slight downtrend in a four-weeks-tight pattern. BlackRock stock also bounced from its 21-day exponential moving average, extending a recent rebound from near the 10-week line. Both moves signaled an early entry opportunity. The financial stock continues to work on a 1,068.34 traditional buy point, according to . Shares traded around 2% below that trigger on Friday. IBD named on Thursday as it became actionable on the 21-day bounce. BlackRock stock owns a Composite Rating of 91, EPS Rating of 76 and RS Rating of 84. In the third quarter, BlackRock earnings trudged up 5%, but beat views, as revenue rose 15%. Earnings are poised to accelerate to a 19% gain in the current quarter. For the full year, analysts now project that BlackRock earnings will speed up to 14.5% growth from 6.8% in 2023. They anticipate a further 12.5% increase next year. Some analysts expect the world's largest asset manager's foray into private credit, including its $12 billion HPS deal, to boost earnings. Amid bitcoin mania, BlackRock is basking in the success of its iShares Bitcoin ETF ( ). The exchange traded fund has surpassed $50 billion in assets, more than double the size of its nearest ETF competitor. Year to date, BlackRock stock sits on a 28.5% gain. That includes a 10% rally in the current quarter. Trip.com Stock Eyes China Stimulus The China-based operator of a one-stop travel platform eyes a 69.67 buy point from a nine-week consolidation near highs. Similar to Emcor, the pattern formed after Trip.com stock hit a 20% profit-taking zone from a September breakout past 58. Volume has been drying up for this China stock as well. Trip.com stock holds a Composite Rating of 97, EPS Rating of 72 and RS Rating of 93. Earnings growth averaged around 51% over the last three quarters. But it continues to slow on a sequential basis, reaching 19% in the latest quarter. Revenue growth did pick up to 20% in the latest quarter, snapping a deceleration trend. Analysts expect Trip.com earnings to leap 32% for the full year and to rise 6% next year. China stocks can be volatile. That is especially true now amid fears of another bout of tit-for-tat tariff wars under President-elect Donald Trump. Further to that, China's Golden Week holiday in early October affirmed a trend in more cautious travel spending, CNBC reported. However, Trip.com and other Chinese stocks are counting on domestic stimulus to reignite growth. Year to date, Trip.com stock has rocketed 92%. That includes a 16% jump in the current quarter. Emcor Stock An Infrastructure Play The building services provider shows a four-weeks-tight pattern with a buy point of 532.38. That entry also marks the all-time high for Emcor stock. The pattern formed after from a September breakout past 401.98. But volume has been drying up as this industrial stock awaits a catalyst for its next leg up. Shares are finding support at a rising 21-day line. Emcor stock flourishes a Composite Rating of 99, EPS Rating of 98 and RS Rating of 95. Earnings growth averaged almost 73% over the last three quarters, above the three-year rate of 45%. Analysts expect Emcor earnings to jump 57% for the full year and to grow 8% next year. The company provides critical infrastructure systems. A 2023 bipartisan infrastructure law pumped billions of dollars into roads, bridges, airports, railroads, ports and more. Year to date, Emcor stock has more than doubled, surging 136%. That includes an 18% jump in the current quarter. Brighter Insurance Outlook For Travelers Stock Shares have carved a cup-with-handle base with a 269.05 buy point. Travelers stock sits about 3% below the entry, holding the 21-day line. The base formed entirely above the 50-day line, a positive sign. IBD had picked the in late November as it eyed a breakout to highs. Travelers stock holds a Composite Rating of 93, EPS Rating of 96 and RS Rating of 80. Earnings growth boomed in the latest two quarters, lapping easy comparisons. The Dow Jones commercial, personal and specialty insurer eyes an earnings turnaround. That comeback reflects higher underwriting volumes, higher interest rates and higher stock markets. Broadly, insurers are recovering from big underwriting losses in recent years. Analysts project Travelers earnings will soar 44% and grow a further 12% in 2025. Year to date, TRV stock has ripped 37% higher. That includes a 12% rally in the current quarter. For other ideas on the best stocks to buy and research, check out the and .
"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" To keep reading, please log in to your account, create a free account, or simply fill out the form below.Pep Guardiola denies rumours of a rift with Kevin De Bruyne
NoneMajor Combat Sports Products Market Driver 2024-2033: Surging Participation In High-Performance Sports